全文获取类型
收费全文 | 2013篇 |
免费 | 108篇 |
国内免费 | 2篇 |
出版年
2023年 | 4篇 |
2022年 | 11篇 |
2021年 | 19篇 |
2020年 | 12篇 |
2019年 | 20篇 |
2018年 | 20篇 |
2017年 | 34篇 |
2016年 | 28篇 |
2015年 | 56篇 |
2014年 | 76篇 |
2013年 | 138篇 |
2012年 | 104篇 |
2011年 | 105篇 |
2010年 | 80篇 |
2009年 | 90篇 |
2008年 | 142篇 |
2007年 | 127篇 |
2006年 | 121篇 |
2005年 | 115篇 |
2004年 | 129篇 |
2003年 | 111篇 |
2002年 | 120篇 |
2001年 | 33篇 |
2000年 | 34篇 |
1999年 | 30篇 |
1998年 | 27篇 |
1997年 | 21篇 |
1996年 | 21篇 |
1995年 | 10篇 |
1994年 | 21篇 |
1993年 | 31篇 |
1992年 | 20篇 |
1991年 | 27篇 |
1990年 | 22篇 |
1989年 | 27篇 |
1988年 | 17篇 |
1987年 | 11篇 |
1986年 | 12篇 |
1985年 | 16篇 |
1984年 | 9篇 |
1983年 | 6篇 |
1982年 | 15篇 |
1981年 | 9篇 |
1980年 | 7篇 |
1979年 | 4篇 |
1978年 | 10篇 |
1977年 | 3篇 |
1974年 | 3篇 |
1971年 | 5篇 |
1970年 | 3篇 |
排序方式: 共有2123条查询结果,搜索用时 250 毫秒
931.
Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice 总被引:2,自引:0,他引:2
Furuyama T Kitayama K Shimoda Y Ogawa M Sone K Yoshida-Araki K Hisatsune H Nishikawa S Nakayama K Nakayama K Ikeda K Motoyama N Mori N 《The Journal of biological chemistry》2004,279(33):34741-34749
Members of the Foxo family, Foxo1 (Fkhr), Foxo3 (Fkhrl1), and Foxo4 (Afx), are mammalian homologs of daf-16, which influences life span and energy metabolism in Caenorhabditis elegans. Mammalian FOXO proteins also play important roles in cell cycle arrest, apoptosis, stress resistance, and energy metabolism. In this study, we generated Foxo1-deficient mice to investigate the physiological role of FOXO1. The Foxo1-deficient mice died around embryonic day 11 because of defects in the branchial arches and remarkably impaired vascular development of embryos and yolk sacs. In vitro differentiation of embryonic stem cells demonstrated that endothelial cells derived from wild-type and Foxo1-deficient embryonic stem cells were able to produce comparable numbers of colonies supported by a layer of OP9 stromal cells. Although the morphology of the endothelial cell colonies was identical in both genotypes in the absence of exogenous vascular endothelial growth factor (VEGF), Foxo1-deficient endothelial cells showed a markedly different morphological response compared with wild-type endothelial cells in the presence of exogenous VEGF. These results suggest that Foxo1 is essential to the ability of endothelial cells to respond properly to a high dose of VEGF, thereby playing a critical role in normal vascular development. 相似文献
932.
933.
ATR/Rad3-like kinases promote the DNA damage checkpoint through regulating Chk1 that restrains the activation of cyclin-dependent kinases. In fission yeast, Crb2, a BRCT-domain protein that is similar to vertebrate 53BP1, plays a crucial role in establishing this checkpoint. We report here that Crb2 regulates DNA damage checkpoint through temporal and dynamic interactions with Rad3, Chk1 and replication factor Cut5. The active complex formation between Chk1 and Crb2 is regulated by Rad3 and became maximal during the checkpoint arrest. Chk1 activation seems to need two steps of interaction changes: the loss of Rad3-Chk1 and Rad3-Crb2 interactions, and the association between hyperphosphorylated forms of Chk1 and Crb2. Chk1 is the major checkpoint kinase for the arrest of DNA polymerase mutants. The in vitro assay of Chk1 showed that its activation requires the presence of Crb2 BRCT. Hyperphosphorylation of Crb2 is also dependent on its intact BRCT. Finally, we show direct interaction between Rad3 and Crb2, which is inhibitory to Rad3 activity. Hence, Crb2 is the first to interact with both Rad3 and Chk1 kinases. 相似文献
934.
935.
Yatani A Kim SJ Kudej RK Wang Q Depre C Irie K Kranias EG Vatner SF Vatner DE 《American journal of physiology. Heart and circulatory physiology》2004,286(6):H2219-H2228
Mammalian hibernators exhibit remarkable resistance to low body temperature, whereas non-hibernating (NHB) mammals develop ventricular dysfunction and arrhythmias. To investigate this adaptive change, we compared contractile and electrophysiological properties of left ventricular myocytes isolated from hibernating (HB) woodchucks (Marmota monax) and control NHB woodchucks. The major findings of this study were the following: 1) the action potential duration in HB myocytes was significantly shorter than in NHB myocytes, but the amplitude of peak contraction was unchanged; 2) HB myocytes had a 33% decreased L-type Ca2+ current (I(Ca)) density and twofold faster I(Ca) inactivation but no change in the current-voltage relationship; 3) there were no changes in the density of inward rectifier K+ current, transient outward K+ current, or Na+/Ca2+ exchange current, but HB myocytes had increased sarcoplasmic reticulum Ca2+ content as estimated from caffeine-induced Na+/Ca2+ exchange current values; 4) expression of the L-type Ca2+ channel alpha(1C)-subunit was decreased by 30% in HB hearts; and 5) mRNA and protein levels of sarco(endo)plasmic reticulum Ca2+-ATPase 2a (SERCA2a), phospholamban, and the Na+/Ca2+ exchanger showed a pattern that is consistent with functional measurements: SERCA2a was increased and phospholamban was decreased in HB relative to NHB hearts with no change in the Na+/Ca2+ exchanger. Thus reduced Ca2+ channel density and faster I(Ca) inactivation coupled to enhanced sarcoplasmic reticulum Ca2+ release may underlie shorter action potentials with sustained contractility in HB hearts. These changes may account for natural resistance to Ca2+ overload-related ventricular dysfunction and point to an important cardioprotective mechanism during true hibernation. 相似文献
936.
Involvement of spinal metabotropic glutamate receptor 5 in the development of tolerance to morphine-induced antinociception 总被引:4,自引:0,他引:4
Narita M Suzuki M Narita M Niikura K Nakamura A Miyatake M Aoki T Yajima Y Suzuki T 《Journal of neurochemistry》2005,94(5):1297-1305
It is well known that prolonged exposure to morphine results in tolerance to morphine-induced antinociception. In the present study, we found that either intrathecal (i.t.) or subcutaneous (s.c.) injection of the selective metabotropic glutamate receptor 5 (mGluR5) antagonist, methyl-6-(phenylethynyl)-pyridine hydrochloride (MPEP), attenuated the development of tolerance to morphine-induced antinociception. Using the receptor binding assay, we found here that the number of mGluR5 in the mouse spinal cord was significantly increased by repeated treatment with morphine. Furthermore, repeated treatment with morphine produced a significant increase in the level of mGluR5 immunoreactivity in the dorsal horn of the mouse spinal cord. Double-labeling experiments showed that the increased mGluR5 was predominantly expressed in the neurons and sparsely expressed in the processes of astrocytes following repeated treatment with morphine. Consistent with these results, the response of Ca2+ to the selective group I mGluR agonist, 3,5-dihydroxyphenylglycine (DHPG), in cultured spinal cord neurons was potently enhanced by 3 days of in vitro treatment with morphine. These findings support the idea that the increased mGluR5 following repeated treatment with morphine leads to enhanced neuronal excitability and synaptic transmission in the dorsal horn of the spinal cord and, in turn, suppresses the morphine-induced antinociception in mice. 相似文献
937.
Xu H Kurihara H Ito T Kikuchi H Yoshida K Yamanokuchi H Asari A 《The Journal of biological chemistry》2005,280(21):20879-20886
It has been reported that disaccharides of the glycosaminoglycans (GAGs), heparin, or heparan sulfate suppress the production of cytokines. Therefore, we examined the effects of GAGs (keratan sulfate, hyaluronan, chondroitin, chondroitin sulfate, and heparin sulfate) disaccharides on production of interleukin (IL)-12, a pivotal cytokine in the Th-1 type immune system. Among the GAG disaccharides, only a keratan sulfate disaccharide, Gal(6-SO(3))-GlcNAc(6-SO(3)) (L4), suppressed IL-12 production in macrophages stimulated with lipopolysaccharides and interferon-gamma. Neither keratan sulfate chains nor keratan sulfate tetrasaccharides elicited any change in the IL-12 production. N-Acetyl-lactosamine, Gal-GlcNAc (LacNAc), also did not change IL-12 production. These results indicated that a certain size, i.e. disaccharide and sulfate, are essential to suppress IL-12 production. L4 was then applied to MRL-lpr/lpr mice, a Th-1 type autoimmune disease model. The treatment of MRL-lpr/lpr mice with L4 1) decreased in serum IL-12, 2) induced apoptosis in T cells in lymph nodes thereby suppressing lymphoaccumulation, and 3) suppressed hypergammaglobulinemia and glomerulonephritis. We showed previously that IL-12 suppresses cell death of T cells, thereby enhancing the lymphoaccumulation in MRL-lpr/lpr mice. Moreover, it has been reported that IL-12 deficiency in MRL-lpr/lpr mice diminishes lymphoaccumulation and delays glomerulonephritis. The treatment with L4 suppressed phosphoprotein kinase C and phosphoinositide 3-kinase expression in macrophages, suggesting that L4 suppresses IL-12 production by inhibiting phosphoprotein kinase C and phosphoinositide 3-kinase pathways. 相似文献
938.
Murakami T Furusawa K Tamai T Yoshikai K Nishikawa M 《Bioorganic & medicinal chemistry letters》2005,15(4):1115-1119
Sphingosine-1-phosphate (S-1P) derivatives such as threo-(2S,3S)-analogues, which are C-3 stereoisomers of natural erythro-(2S,3R)-S-1P, have been synthesized starting from l-serine or (1S,2S)-2-amino-1-aryl-1,3-propanediols (6). threo-(1S,2R)-2-Amino-1-aryl-3-bromopropanols (HBr salt) have also been prepared from 6. The threo-S-1Ps and the threo-amino-bromide derivatives have shown potent inhibitory activity against Ca(2+) ion mobilization in HL60 cells induced by erythro-S-1P, suggesting that these compounds would compete with cell surface EDG/S1P receptors. 相似文献
939.
Andrea Vaupel Philipp Holzer Stephane Ferretti Vito Guagnano Joerg Kallen Robert Mah Keiichi Masuya Stephan Ruetz Caroline Rynn Achim Schlapbach Thérèse Stachyra Stefan Stutz Milen Todorov Sébastien Jeay Pascal Furet 《Bioorganic & medicinal chemistry letters》2018,28(20):3404-3408
Small molecule inhibitors of the p53-MDM2 protein complex are under intense investigation in clinical trials as anti-cancer agents, including our first generation inhibitor NVP-CGM097. We recently described the rational design of a novel pyrazolopyrrolidinone core as a new lead structure and now we report on the synthesis and optimization of this to provide a highly potent lead compound. This new compound displayed excellent oral efficacy in our preclinical mechanistic in vivo model and marked a significant milestone towards the identification of our second generation clinical candidate NVP-HDM201. 相似文献
940.
Fang Cheng Birgitta Havsmark Katsukiyo Sakurai Hiroko Habuchi Sakaru Suzuki Keiichi Yoshida Lars-Ake Fransson 《Glycoconjugate journal》1997,14(2):297-305
By supplying skin fibroblasts with different concentrations of the galactosaminoglycan chain-primer p-hydroxyphenyl-O-β-D-xylopyranoside we have produced and recovered glycan-chains that were subsequently radio-iodinated in the hydroxyphenyl
group and subjected to sequence analysis by using graded enzymic treatment followed by a combination of gel chromatography
and electrophoresis. Fragments extending from the tagged reducing end to the cleavage-point were identified and quantified.
Degradation by chondroitin B lyase of chains primed at 0.1 or 0.5 mM xyloside gave profiles indicating a periodic and wave-like
distribution of iduronate-containing repeats, with high incidence around positions 2, 5 and onwards, whereas in chains produced
at 1.0 mM xyloside the incidence of iduronate was similar in positions 1–4 and then declined. Degradation by chondroitin AC
lyase indicated a high incidence of glucuronate in or near the linkage-region. There was a relatively uniform degree of sulfation
in chains primed at low xyloside concentration, whereas chains primed at 1.0 mM xyloside gave very heterogeneous charge-patterns
in all segments of the chain, including the linkage-region, giving the impression that adequate sulfation, probably at C-4
and at the first opportunity, is necessary to obtain an ordered and periodic epimerization pattern. Abbreviations:CS, chondroitin
sulfate; DS, dermatan sulfate; GAG, glycosaminoglycan; Gal, D-galactose, GaINAc, N-acetyl-D-galactosamine; GlcUA, D-glucuronic
acid; GlyUA, glycuronic acid; ΔGlyUA, 4,5-unsaturated glycuronic acid; IdoUA, L-iduronic acid; Xyl-Phe-OH, p-hydroxyphenyl-O-β-D-xylopyranoside;
Xyl, D-xylose
This revised version was published online in November 2006 with corrections to the Cover Date. 相似文献